Bridge Innovation & Business Development

We serve as the hub for all commercialization activities at UMass Chan Medical School – a world-class research institution in Worcester, Mass. Our breakthrough research includes the Nobel prize-winning discovery of RNA interference (RNAi) and gene therapies for rare diseases, including Canavan Disease, Tay-Sachs, Spinal Muscular Atrophy (SMA) and more. Our mission is to create a “bridge” between UMass Chan and the external life science ecosystem to support innovative research, protect intellectual property, and facilitate commercialization to help our community, the Commonwealth, and the world. What we do ✅ Protect Intellectual Property (IP) ✅ Sponsored Research Agreements ✅ Licensing and New Companies Partnering with Bridge means access to diverse innovations available for licensing, world-renowned research expertise, start-up opportunities, investment opportunities, and more.